MedWatch

Danish biotech company considers global partnership

One of Denmark’s most promising biotech companies has introduced one of its great drug-hopes for the first time at the recently held J.P. Morgan conference in San Francisco.

Foto: Colourbox

The chairman of the Danish biotech company Forward Pharma has previously revealed that the company is developing a groundbreaking drug for the treatment of psoriasis.

Last week at the J.P. Morgan conference Forward Pharma shed even more light on the future for its promising candidate drug and presented the companyto the major players of the pharmaceutical industry. The purpose was to assess the opportunity for a global partnership as an alternative to commercializing the company on its own, says COO Peder Andersen in an interview with the journal BioCentury.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier